# Bolden Therapeutics

**Canonical:** https://apis.io/providers/bolden-therapeutics/  
**Website:** https://www.boldentherapeutics.com/  
**APIs profiled:** 0

Bolden Therapeutics is a biotech company focused on developing therapies that promote neurogenesis to treat neurological diseases. Their approach aims to improve lives of millions by creating antisense oligonucleotide treatments that increase the formation of new brain cells, addressing cognitive decline and memory impairment.

## Kin Score — 3.0 / 100 (minimal)

Scored 2026-10-04 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Bolden Therapeutics Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biotechnology, Neurogenesis, Therapeutics, Antisense

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/bolden-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.